The results showed that treatment of CFF‐1 dramatically decreased the protein levels of Ki‐67, p‐EGFR (Y1173), and p‐AKT (S473) in tumor tissues in vivo (Fig. 8E). This evidence concerns the gene EGFR and neoplasm.